title: Treatment-related acute myeloid leukemia characterized by t(11;20)(p15;q11) and del(9)(q22).
authors.forename: Motti
authors.initials: M
authors.lastname: Haimi
authors.forename: Haimi
authors.initials: H
authors.lastname: Motti
authors.forename: Irit
authors.initials: I
authors.lastname: Avivi
authors.forename: Avivi
authors.initials: A
authors.lastname: Irit
authors.forename: Nivin
authors.initials: N
authors.lastname: Moustafa
authors.forename: Moustafa
authors.initials: M
authors.lastname: Nivin
authors.forename: Olfat
authors.initials: O
authors.lastname: Aboleil
authors.forename: Aboleil
authors.initials: A
authors.lastname: Olfat
authors.forename: Ruth
authors.initials: R
authors.lastname: Gershoni-Baruch
authors.forename: Gershoni-Baruch
authors.initials: GB
authors.lastname: Ruth
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002872:Chromosome Deletion; D002880:Chromosomes, Human, Pair 11 / Q000648:ultrastructure; D002890:Chromosomes, Human, Pair 20 / Q000648:ultrastructure; D002899:Chromosomes, Human, Pair 9 / Q000648:ultrastructure; D005260:Female; D006801:Humans; D007948:Leukemia, Monocytic, Acute / Q000139:chemically induced* / Q000175:diagnosis* / Q000235:genetics; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000175:diagnosis* / Q000235:genetics; D012074:Remission Induction; D014178:Translocation, Genetic
chemical_list: D000970:Antineoplastic Agents